| Field | Description |
|---|---|
| SampleID | Name of the sample |
| TrimReads | Total number of reads after quality filtering |
| MeanReadLen | Average read length after quality filtering |
| Contigs | Number of contigs of the draft genome (>200bp) |
| GenomeLength | Length (bp) of the draft genome |
| LargestContig | Length (bp) of the largest contig in the genome |
| N50 | Length of the smallest contig in the set that contains the fewest (largest) contigs whose combined length represents at least 50% of the assembly |
| GC-Content | GC content (%) of the draft genome |
| Depth | Number of times each nucleotide position in the draft genome has a read that aligns to that position |
| SampleID | TrimReads | MeanReadLen | Contigs | GenomeLength | LargestContig | N50 | GC-Content | Depth |
|---|---|---|---|---|---|---|---|---|
| SRR8948878 | 1595020 | 149 | 68 | 3101402 | 545479 | 273671 | 37.21 | 76X |
| SRR8948879 | 1588168 | 149 | 79 | 3010836 | 603711 | 179463 | 37.44 | 78X |
| SRR8948880 | 1594518 | 149 | 102 | 3166205 | 417860 | 239597 | 37.18 | 75X |
| SRR8948881 | 1591214 | 149 | 44 | 2924312 | 516731 | 202453 | 37.46 | 81X |
| SRR8948882 | 1586702 | 149 | 170 | 2925331 | 107207 | 46219 | 37.69 | 80X |
| SRR8948883 | 1579276 | 149 | 180 | 2964061 | 113751 | 44888 | 37.74 | 79X |
| SRR8948884 | 1591394 | 149 | 57 | 2934130 | 644112 | 179342 | 37.47 | 80X |
| SRR8948885 | 1584504 | 149 | 59 | 3363692 | 424585 | 243114 | 40.43 | 70X |
| SRR8948886 | 1584116 | 149 | 56 | 2786637 | 344853 | 172313 | 38.08 | 84X |
| SRR8948887 | 1585296 | 149 | 89 | 2984341 | 603711 | 185199 | 37.49 | 79X |
| SRR8948888 | 1576542 | 149 | 57 | 3024061 | 544043 | 207386 | 37.28 | 77X |
| SRR8948889 | 1590020 | 149 | 290 | 5897762 | 544519 | 66637 | 37.49 | 40X |
| SRR8948890 | 1588164 | 149 | 52 | 3016695 | 544186 | 207384 | 37.27 | 78X |
| SRR8948891 | 1589798 | 149 | 69 | 3037920 | 544195 | 219893 | 37.30 | 77X |
## Warning: `arrange_()` is deprecated as of dplyr 0.7.0.
## Please use `arrange()` instead.
## See vignette('programming') for more help
## This warning is displayed once every 8 hours.
## Call `lifecycle::last_warnings()` to see where this warning was generated.
Average number of reads per sample = 1587481
| Field | Description |
|---|---|
| Contig | Contig name where the gene was found |
| Start | Start position of the gene within the contig |
| End | End position of the gene within the contig |
| Gene | Antibiotic resistance gene |
| Gaps | Gaps in subject (genome) and query (antibiotic resistance gene) |
| Coverage | Proportion (%) of the gene covered |
| Identity | Proportion (%) of exact nucleotide matches |
| Accession | Accesion number of the antibiotic resistance gene |
| Product | Antibiotic resistance gene product |
| Resistance | Antibiotic that the gene confers resistance to |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00007 | 82257 | 82754 | dfrG_1 | 0/0 | 100 | 100.0 | AB205645 | dfrG | Trimethoprim |
| contig00027 | 2694 | 3456 | erm(B)_18 | 1/1 | 100 | 99.1 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00004 | 172990 | 174486 | lsa(A)_1 | 0/0 | 100 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00002 | 31907 | 33826 | tet(M)_10 | 0/0 | 100 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 78017 | 78511 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00007 | 82257 | 82754 | dfrG | 0/0 | 100.0 | 100.0 | AB205645:1012-1510 | dfrG is a plasmid-encoded dihydrofolate reductase found in Staphylococcus aureus | diaminopyrimidine |
| contig00008 | 24880 | 26607 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00008 | 23268 | 24321 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 519193 | 520347 | emeA | 1/27 | 97.7 | 97.1 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00027 | 2719 | 3464 | ErmB | 1/1 | 99.9 | 99.5 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00004 | 172990 | 174486 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00002 | 31907 | 33826 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00027 | 2719 | 3456 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 172990 | 174486 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00006 | 213113 | 213946 | (MLS)mph(D) | 0/0 | 100 | 99.8 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 31907 | 33826 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 78017 | 78511 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| contig00007 | 82257 | 82754 | (Tmt)dfrG | 0/0 | 100 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00027 | 2719 | 3456 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 172990 | 174486 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00006 | 213113 | 213946 | (MLS)mph(D) | 0/0 | 100 | 99.8 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 31907 | 33826 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 78017 | 78511 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| contig00007 | 82257 | 82754 | (Tmt)dfrG | 0/0 | 100 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 78017 | 78511 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00007 | 82257 | 82754 | DFRG | 0/0 | 100.0 | 100.0 | MEG_2579 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRG | NA |
| contig00008 | 24966 | 26400 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00008 | 23268 | 24321 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00027 | 2694 | 3456 | ERMB | 1/1 | 100.0 | 99.1 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00004 | 172990 | 174486 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00002 | 31907 | 33826 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00028 | 3187 | 3834 | cat(pC221)_1 | 0/0 | 100 | 97.7 | X02529 | cat(pC221) | Chloramphenicol |
| contig00011 | 56585 | 58081 | lsa(A)_1 | 0/0 | 100 | 99.4 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00007 | 124979 | 126898 | tet(M)_13 | 0/0 | 100 | 99.9 | AM990992 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| contig00033 | 2093 | 4699 | VanHAX_2 | 0/0 | 100 | 100.0 | M97297 | VanHAX | Vancomycin, Teicoplanin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 182045 | 182539 | dfrE | 0/0 | 100.0 | 97.6 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00013 | 25119 | 26846 | efrA | 0/0 | 100.0 | 99.3 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00013 | 23507 | 24560 | efrB | 6/6 | 96.7 | 97.6 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00006 | 173315 | 174469 | emeA | 1/27 | 97.7 | 97.0 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00028 | 3187 | 3834 | Enterococcus_faecalis_chloramphenicol_acetyltransferase | 0/0 | 100.0 | 100.0 | X92945.2:9582-8934 | A chloramphenicol acetyltransferase and resistance determinant described in Enterococcus faecalis | phenicol |
| contig00011 | 56585 | 58081 | lsaA | 0/0 | 100.0 | 99.4 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00007 | 124979 | 126898 | tetM | 0/0 | 100.0 | 99.9 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| contig00045 | 728 | 1045 | tetU | 0/0 | 100.0 | 99.4 | U01917.1:412-730 | Tetracycline-resistant determinant encoded on the plasmid pKQ10 in Enterococcus faecium | tetracycline |
| contig00033 | 3054 | 4085 | vanA | 0/0 | 100.0 | 100.0 | M97297:6979-8010 | VanA is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Lac an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It has been isolated from VREs. It is associated with both vancomycin and teicoplanin resistance. | glycopeptide |
| contig00033 | 2093 | 3061 | vanHA | 0/0 | 100.0 | 100.0 | M97297:6018-6986 | vanHA also known as vanH is a vanH variant in the vanA gene cluster | glycopeptide |
| contig00033 | 51 | 746 | vanRA | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | vanRA also known as vanR is a vanR variant found in the vanA gene cluster | glycopeptide |
| contig00033 | 724 | 1878 | vanSA | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | vanSA also known as vanS is a vanS variant found in the vanA gene cluster | glycopeptide |
| contig00033 | 4091 | 4699 | vanXA | 0/0 | 100.0 | 100.0 | M97297:8016-8624 | vanXA also known as vanX is a vanX variant found in the vanA gene cluster | glycopeptide |
| contig00028 | 9615 | 10100 | vanZA | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | vanZA also known as vanZ is a vanZ variant found in the vanA gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00033 | 3054 | 4085 | (Gly)vanA-A | 0/0 | 100 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00033 | 2093 | 3061 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00033 | 51 | 746 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00033 | 724 | 1878 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00033 | 4091 | 4699 | (Gly)vanX-A | 0/0 | 100 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00028 | 9615 | 10100 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00011 | 56585 | 58081 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 490345 | 491178 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00028 | 3187 | 3834 | (Phe)cat-pC221 | 0/0 | 100 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00007 | 124979 | 126898 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00045 | 728 | 1045 | (Tet)tetU | 0/0 | 100 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00001 | 182045 | 182539 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00033 | 3054 | 4085 | (Gly)vanA-A | 0/0 | 100 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00033 | 2093 | 3061 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00033 | 51 | 746 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00033 | 724 | 1878 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00033 | 4091 | 4699 | (Gly)vanX-A | 0/0 | 100 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00028 | 9615 | 10100 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00011 | 56585 | 58081 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 490345 | 491178 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00028 | 3187 | 3834 | (Phe)cat-pC221 | 0/0 | 100 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00007 | 124979 | 126898 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00045 | 728 | 1045 | (Tet)tetU | 0/0 | 100 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00001 | 182045 | 182539 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00028 | 3187 | 3834 | CATA | 0/0 | 100.0 | 100.0 | MEG_1591 | Drugs:Phenicol:Chloramphenicol_acetyltransferases:CATA | NA |
| contig00001 | 182045 | 182539 | DFRE | 0/0 | 100.0 | 97.6 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00013 | 25205 | 26639 | EFRA | 1/1 | 98.5 | 99.1 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00013 | 23507 | 24560 | EFRB | 6/6 | 96.7 | 97.6 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00011 | 56585 | 58081 | LSA | 0/0 | 100.0 | 99.4 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00007 | 124979 | 126898 | TETM | 0/0 | 100.0 | 99.9 | MEG_7145 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| contig00045 | 728 | 1045 | TETU | 0/0 | 100.0 | 99.4 | MEG_7204 | Drugs:Tetracyclines:Tetracycline_resistance_MFS_efflux_regulator:TETU | NA |
| contig00033 | 2093 | 4699 | VANHA | 0/0 | 100.0 | 100.0 | MEG_7410 | Drugs:Glycopeptides:VanA-type_resistance_protein:VANHA | NA |
| contig00028 | 9615 | 10100 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7452 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00033 | 51 | 746 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7453 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00033 | 724 | 1878 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7454 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00062 | 1 | 881 | ant(6)-Ia_1 | 0/0 | 96.9 | 100.0 | AF330699 | ant(6)-Ia | Streptomycin |
| contig00039 | 1557 | 2204 | cat(pC221)_1 | 0/0 | 100.0 | 97.7 | X02529 | cat(pC221) | Chloramphenicol |
| contig00008 | 82257 | 82754 | dfrG_1 | 0/0 | 100.0 | 100.0 | AB205645 | dfrG | Trimethoprim |
| contig00031 | 2694 | 3456 | erm(B)_18 | 1/1 | 100.0 | 99.1 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00004 | 172990 | 174486 | lsa(A)_1 | 0/0 | 100.0 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00002 | 32394 | 34313 | tet(M)_10 | 0/0 | 100.0 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| contig00040 | 1 | 2426 | VanHAX_2 | 0/0 | 93.1 | 100.0 | M97297 | VanHAX | Vancomycin, Teicoplanin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00062 | 51 | 881 | aad(6) | 0/0 | 100.0 | 100.0 | AY712687:0-831 | aad(6) is a plasmid-encoded aminoglycoside nucleotidyltransferase gene in E. faecalis and Streptococcus oralis | aminoglycoside |
| contig00009 | 78017 | 78511 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00008 | 82257 | 82754 | dfrG | 0/0 | 100.0 | 100.0 | AB205645:1012-1510 | dfrG is a plasmid-encoded dihydrofolate reductase found in Staphylococcus aureus | diaminopyrimidine |
| contig00003 | 24880 | 26607 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00003 | 23268 | 24321 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 25016 | 26170 | emeA | 1/27 | 97.7 | 97.1 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00039 | 1557 | 2204 | Enterococcus_faecalis_chloramphenicol_acetyltransferase | 0/0 | 100.0 | 100.0 | X92945.2:9582-8934 | A chloramphenicol acetyltransferase and resistance determinant described in Enterococcus faecalis | phenicol |
| contig00031 | 2719 | 3464 | ErmB | 1/1 | 99.9 | 99.5 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00004 | 172990 | 174486 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00002 | 32394 | 34313 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| contig00046 | 728 | 1045 | tetU | 0/0 | 100.0 | 99.4 | U01917.1:412-730 | Tetracycline-resistant determinant encoded on the plasmid pKQ10 in Enterococcus faecium | tetracycline |
| contig00040 | 781 | 1812 | vanA | 0/0 | 100.0 | 100.0 | M97297:6979-8010 | VanA is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Lac an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It has been isolated from VREs. It is associated with both vancomycin and teicoplanin resistance. | glycopeptide |
| contig00040 | 1818 | 2426 | vanXA | 0/0 | 100.0 | 100.0 | M97297:8016-8624 | vanXA also known as vanX is a vanX variant found in the vanA gene cluster | glycopeptide |
| contig00056 | 380 | 1291 | vanYA | 0/0 | 100.0 | 100.0 | M97297:9052-9963 | vanYA also known as vanY is a vanY variant found in the vanA gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00062 | 1 | 881 | (AGly)ant6-Ia | 0/0 | 96.9 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00040 | 781 | 1812 | (Gly)vanA-A | 0/0 | 100.0 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00040 | 1818 | 2426 | (Gly)vanX-A | 0/0 | 100.0 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00056 | 380 | 1291 | (Gly)vanY-A | 0/0 | 100.0 | 100.0 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00031 | 2719 | 3456 | (MLS)erm(B) | 0/0 | 100.0 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 172990 | 174486 | (MLS)lsa(A) | 0/0 | 100.0 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00005 | 213113 | 213946 | (MLS)mph(D) | 0/0 | 100.0 | 99.8 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00039 | 1557 | 2204 | (Phe)cat-pC221 | 0/0 | 100.0 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00002 | 32394 | 34313 | (Tet)tetM | 0/0 | 100.0 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00046 | 728 | 1045 | (Tet)tetU | 0/0 | 100.0 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00009 | 78017 | 78511 | (Tmt)dfrE | 0/0 | 100.0 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| contig00008 | 82257 | 82754 | (Tmt)dfrG | 0/0 | 100.0 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00062 | 1 | 881 | (AGly)ant6-Ia | 0/0 | 96.9 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00040 | 781 | 1812 | (Gly)vanA-A | 0/0 | 100.0 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00040 | 1818 | 2426 | (Gly)vanX-A | 0/0 | 100.0 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00056 | 380 | 1291 | (Gly)vanY-A | 0/0 | 100.0 | 100.0 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00031 | 2719 | 3456 | (MLS)erm(B) | 0/0 | 100.0 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 172990 | 174486 | (MLS)lsa(A) | 0/0 | 100.0 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00005 | 213113 | 213946 | (MLS)mph(D) | 0/0 | 100.0 | 99.8 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00039 | 1557 | 2204 | (Phe)cat-pC221 | 0/0 | 100.0 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00002 | 32394 | 34313 | (Tet)tetM | 0/0 | 100.0 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00046 | 728 | 1045 | (Tet)tetU | 0/0 | 100.0 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00009 | 78017 | 78511 | (Tmt)dfrE | 0/0 | 100.0 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| contig00008 | 82257 | 82754 | (Tmt)dfrG | 0/0 | 100.0 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00062 | 1 | 881 | ANT6 | 0/0 | 96.9 | 100.0 | MEG_994 | Drugs:Aminoglycosides:Aminoglycoside_O-nucleotidyltransferases:ANT6 | NA |
| contig00039 | 1557 | 2204 | CATA | 0/0 | 100.0 | 100.0 | MEG_1591 | Drugs:Phenicol:Chloramphenicol_acetyltransferases:CATA | NA |
| contig00009 | 78017 | 78511 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00008 | 82257 | 82754 | DFRG | 0/0 | 100.0 | 100.0 | MEG_2579 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRG | NA |
| contig00003 | 24966 | 26400 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00003 | 23268 | 24321 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00031 | 2694 | 3456 | ERMB | 1/1 | 100.0 | 99.1 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00004 | 172990 | 174486 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00002 | 32394 | 34313 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| contig00046 | 728 | 1045 | TETU | 0/0 | 100.0 | 99.4 | MEG_7204 | Drugs:Tetracyclines:Tetracycline_resistance_MFS_efflux_regulator:TETU | NA |
| contig00040 | 1 | 2426 | VANHA | 0/0 | 93.1 | 100.0 | MEG_7410 | Drugs:Glycopeptides:VanA-type_resistance_protein:VANHA | NA |
| contig00056 | 380 | 1291 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7458 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00010 | 56301 | 57797 | lsa(A)_1 | 0/0 | 100 | 99.4 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00029 | 524 | 2464 | tet(S)_3 | 0/0 | 100 | 99.9 | X92946 | tet(S) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 72187 | 72681 | dfrE | 0/0 | 100.0 | 97.6 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00007 | 141691 | 143418 | efrA | 0/0 | 100.0 | 99.2 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00007 | 143977 | 145030 | efrB | 6/6 | 96.7 | 97.6 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00006 | 170401 | 171555 | emeA | 1/27 | 97.7 | 96.9 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00010 | 56301 | 57797 | lsaA | 0/0 | 100.0 | 99.4 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00029 | 524 | 2449 | tetS | 0/0 | 100.0 | 100.0 | L09756:0-1926 | Tet(S) is a ribosomal protection protein found in Gram-positive and Gram-negative strains. It is similar to tet(M) and tet(O). | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00010 | 56301 | 57797 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 408745 | 409578 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00029 | 524 | 2449 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00001 | 72187 | 72681 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00010 | 56301 | 57797 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 408745 | 409578 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00029 | 524 | 2449 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00001 | 72187 | 72681 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 72187 | 72681 | DFRE | 0/0 | 100.0 | 97.6 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00007 | 141898 | 143332 | EFRA | 1/1 | 98.5 | 99.0 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00007 | 143977 | 145030 | EFRB | 6/6 | 96.7 | 97.6 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00010 | 56301 | 57797 | LSA | 0/0 | 100.0 | 99.4 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00029 | 524 | 2464 | TETS | 0/0 | 100.0 | 99.9 | MEG_7200 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETS | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00126 | 376 | 1719 | aac(6’)-aph(2’’)_1 | 0/0 | 93.3 | 99.9 | M13771 | aac(6’)-aph(2’’) | Amikacin, Gentamicin, Tobramycin |
| contig00010 | 31434 | 31982 | aac(6’)-Ii_1 | 0/0 | 100.0 | 99.6 | L12710 | aac(6’)-Ii | Amikacin, Tobramycin |
| contig00064 | 6660 | 7568 | ant(6)-Ia_1 | 0/0 | 100.0 | 100.0 | AF330699 | ant(6)-Ia | Streptomycin |
| contig00064 | 8200 | 8994 | aph(3’)-III_1 | 0/0 | 100.0 | 100.0 | M26832 | aph(3’)-III | Amikacin |
| contig00064 | 12761 | 13523 | erm(B)_18 | 1/1 | 100.0 | 99.5 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00004 | 80444 | 81922 | msr(C)_1 | 0/0 | 100.0 | 98.9 | AY004350 | msr(C) | Erythromycin, Telithromycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00073 | 4890 | 7496 | VanHAX_2 | 0/0 | 100.0 | 99.9 | M97297 | VanHAX | Vancomycin, Teicoplanin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00126 | 376 | 1719 | AAC(6’)-Ie-APH(2’’)-Ia | 0/0 | 93.3 | 99.9 | GU565967.1:26419-24979 | AAC(6’)-Ie-APH(2’’)-Ia is an aminoglycoside acetyltransferase encoded by plasmids and transposons in S. aureus E. faecalis E. faecium and Staphylococcus warneri | aminoglycoside |
| contig00010 | 31434 | 31982 | AAC(6’)-Ii | 0/0 | 100.0 | 99.6 | L12710:0-549 | AAC(6’)-Ii is a chromosomal-encoded aminoglycoside acetyltransferase in Enterococcus spp. | aminoglycoside |
| contig00064 | 6738 | 7568 | aad(6) | 0/0 | 100.0 | 100.0 | AY712687:0-831 | aad(6) is a plasmid-encoded aminoglycoside nucleotidyltransferase gene in E. faecalis and Streptococcus oralis | aminoglycoside |
| contig00064 | 8200 | 8994 | APH(3’)-IIIa | 0/0 | 100.0 | 100.0 | CP004067:52914-53709 | APH(3’)-IIIa is a plasmid-encoded aminoglycoside phosphotransferase in S. aureus and Enterococcus spp. | aminoglycoside |
| contig00008 | 39083 | 40369 | efmA | 0/0 | 100.0 | 100.0 | AB467372.1:284-1571 | efmA is an MFS transporter permease in E. faecium. | fluoroquinolone, macrolide |
| contig00064 | 12753 | 13498 | ErmB | 1/1 | 99.9 | 99.2 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00004 | 80444 | 81922 | msrC | 0/0 | 100.0 | 94.4 | AF313494:0-1479 | msrC is a chromosomal-encoded ABC-F subfamily protein expressed in Enterococcus faecium that confers resistance to erythromycin and other macrolide and streptogramin B antibiotics. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00064 | 7565 | 8107 | SAT-4 | 0/0 | 100.0 | 99.8 | U01945:373-916 | SAT-4 is a plasmid-mediated streptothricin acetyltransferase and streptothricin (a nucleoside antibiotic) resistant determinant. Originally described from a Campylobacter coli BE/G4 plasmid gene sequence by Jacob et al 1994. | nucleoside |
| contig00073 | 5504 | 6535 | vanA | 0/0 | 100.0 | 99.9 | M97297:6979-8010 | VanA is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Lac an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It has been isolated from VREs. It is associated with both vancomycin and teicoplanin resistance. | glycopeptide |
| contig00073 | 6528 | 7496 | vanHA | 0/0 | 100.0 | 100.0 | M97297:6018-6986 | vanHA also known as vanH is a vanH variant in the vanA gene cluster | glycopeptide |
| contig00073 | 8843 | 9538 | vanRA | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | vanRA also known as vanR is a vanR variant found in the vanA gene cluster | glycopeptide |
| contig00073 | 7711 | 8865 | vanSA | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | vanSA also known as vanS is a vanS variant found in the vanA gene cluster | glycopeptide |
| contig00073 | 4890 | 5498 | vanXA | 0/0 | 100.0 | 99.8 | M97297:8016-8624 | vanXA also known as vanX is a vanX variant found in the vanA gene cluster | glycopeptide |
| contig00073 | 3551 | 4462 | vanYA | 0/0 | 100.0 | 99.8 | M97297:9052-9963 | vanYA also known as vanY is a vanY variant found in the vanA gene cluster | glycopeptide |
| contig00073 | 2913 | 3398 | vanZA | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | vanZA also known as vanZ is a vanZ variant found in the vanA gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00126 | 376 | 1719 | (AGly)aac6-Aph2 | 0/0 | 93.3 | 99.9 | M13771:304-1743 | (AGly)aac6-Aph2 | NA |
| contig00010 | 31434 | 31982 | (AGly)aac6-Ii | 0/0 | 100.0 | 99.6 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00064 | 6660 | 7568 | (AGly)ant6-Ia | 0/0 | 100.0 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00064 | 8200 | 8994 | (AGly)aph(3’’)-III | 0/0 | 100.0 | 100.0 | V01547:535-1329 | (AGly)aph(3’’)-III | NA |
| contig00064 | 7565 | 8107 | (AGly)sat4A | 0/0 | 100.0 | 100.0 | X92945:38870-39412 | (AGly)sat4A | NA |
| contig00073 | 5504 | 6535 | (Gly)vanA-A | 0/0 | 100.0 | 99.9 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00073 | 6528 | 7496 | (Gly)vanH-A | 0/0 | 100.0 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00073 | 8843 | 9538 | (Gly)vanR-A | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00073 | 7711 | 8865 | (Gly)vanS-A | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00073 | 4890 | 5498 | (Gly)vanX-A | 0/0 | 100.0 | 99.8 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00073 | 3551 | 4462 | (Gly)vanY-A | 0/0 | 100.0 | 99.8 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00073 | 2913 | 3398 | (Gly)vanZ-A | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00064 | 12761 | 13498 | (MLS)erm(B) | 0/0 | 100.0 | 99.9 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 80444 | 81922 | (MLS)msr(C) | 0/0 | 100.0 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00126 | 376 | 1719 | (AGly)aac6-Aph2 | 0/0 | 93.3 | 99.9 | M13771:304-1743 | (AGly)aac6-Aph2 | NA |
| contig00010 | 31434 | 31982 | (AGly)aac6-Ii | 0/0 | 100.0 | 99.6 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00064 | 6660 | 7568 | (AGly)ant6-Ia | 0/0 | 100.0 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00064 | 8200 | 8994 | (AGly)aph(3’’)-III | 0/0 | 100.0 | 100.0 | V01547:535-1329 | (AGly)aph(3’’)-III | NA |
| contig00064 | 7565 | 8107 | (AGly)sat4A | 0/0 | 100.0 | 100.0 | X92945:38870-39412 | (AGly)sat4A | NA |
| contig00073 | 5504 | 6535 | (Gly)vanA-A | 0/0 | 100.0 | 99.9 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00073 | 6528 | 7496 | (Gly)vanH-A | 0/0 | 100.0 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00073 | 8843 | 9538 | (Gly)vanR-A | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00073 | 7711 | 8865 | (Gly)vanS-A | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00073 | 4890 | 5498 | (Gly)vanX-A | 0/0 | 100.0 | 99.8 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00073 | 3551 | 4462 | (Gly)vanY-A | 0/0 | 100.0 | 99.8 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00073 | 2913 | 3398 | (Gly)vanZ-A | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00064 | 12761 | 13498 | (MLS)erm(B) | 0/0 | 100.0 | 99.9 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00004 | 80444 | 81922 | (MLS)msr(C) | 0/0 | 100.0 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00010 | 31434 | 31982 | AAC6-PRIME | 0/0 | 100.0 | 100.0 | MEG_84 | Drugs:Aminoglycosides:Aminoglycoside_N-acetyltransferases:AAC6-PRIME | NA |
| contig00126 | 374 | 1719 | AAC6-PRIME | 0/0 | 93.2 | 99.9 | MEG_364 | Drugs:Aminoglycosides:Aminoglycoside_N-acetyltransferases:AAC6-PRIME | NA |
| contig00064 | 6660 | 7568 | ANT6 | 0/0 | 100.0 | 100.0 | MEG_994 | Drugs:Aminoglycosides:Aminoglycoside_O-nucleotidyltransferases:ANT6 | NA |
| contig00064 | 8200 | 8994 | APH2-DPRIME | 0/0 | 100.0 | 100.0 | MEG_1016 | Drugs:Aminoglycosides:Aminoglycoside_O-phosphotransferases:APH2-DPRIME | NA |
| contig00008 | 39083 | 40369 | EFMA | 0/0 | 100.0 | 100.0 | MEG_2704 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_MFS_efflux_pumps:EFMA | NA |
| contig00064 | 12761 | 13523 | ERMB | 1/1 | 100.0 | 99.5 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00004 | 80444 | 81922 | MSRC | 0/0 | 100.0 | 98.9 | MEG_4071 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:MSRC | NA |
| contig00064 | 7565 | 8107 | SAT | 0/0 | 100.0 | 100.0 | MEG_6166 | Drugs:Nucleosides:Streptothricin_acetyltransferase:SAT | NA |
| contig00073 | 4890 | 7496 | VANHA | 0/0 | 100.0 | 99.9 | MEG_7410 | Drugs:Glycopeptides:VanA-type_resistance_protein:VANHA | NA |
| contig00073 | 2913 | 3398 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7452 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00073 | 3551 | 4462 | VANRA | 0/0 | 100.0 | 99.8 | MEG_7458 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00073 | 7711 | 8865 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7454 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00073 | 8843 | 9538 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7453 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00014 | 38383 | 38931 | aac(6’)-Ii_1 | 0/0 | 100 | 98.9 | L12710 | aac(6’)-Ii | Amikacin, Tobramycin |
| contig00108 | 2185 | 3093 | ant(6)-Ia_1 | 0/0 | 100 | 100.0 | AF330699 | ant(6)-Ia | Streptomycin |
| contig00080 | 4495 | 5142 | cat(pC221)_1 | 0/0 | 100 | 97.7 | X02529 | cat(pC221) | Chloramphenicol |
| contig00137 | 136 | 898 | erm(B)_18 | 1/1 | 100 | 99.0 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00003 | 56772 | 58250 | msr(C)_1 | 0/0 | 100 | 98.9 | AY004350 | msr(C) | Erythromycin, Telithromycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00021 | 22046 | 23965 | tet(M)_13 | 0/0 | 100 | 100.0 | AM990992 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| contig00097 | 2093 | 4699 | VanHAX_2 | 0/0 | 100 | 100.0 | M97297 | VanHAX | Vancomycin, Teicoplanin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00014 | 38383 | 38931 | AAC(6’)-Ii | 0/0 | 100.0 | 98.9 | L12710:0-549 | AAC(6’)-Ii is a chromosomal-encoded aminoglycoside acetyltransferase in Enterococcus spp. | aminoglycoside |
| contig00108 | 2263 | 3093 | aad(6) | 0/0 | 100.0 | 100.0 | AY712687:0-831 | aad(6) is a plasmid-encoded aminoglycoside nucleotidyltransferase gene in E. faecalis and Streptococcus oralis | aminoglycoside |
| contig00070 | 4109 | 4604 | dfrF | 1/1 | 100.0 | 99.6 | AF028812:392-887 | dfrF is a chromosome-encoded dihydrofolate reductase found in Streptococcus pyogenes | diaminopyrimidine |
| contig00006 | 37430 | 38716 | efmA | 0/0 | 100.0 | 100.0 | AB467372.1:284-1571 | efmA is an MFS transporter permease in E. faecium. | fluoroquinolone, macrolide |
| contig00080 | 4495 | 5142 | Enterococcus_faecalis_chloramphenicol_acetyltransferase | 0/0 | 100.0 | 100.0 | X92945.2:9582-8934 | A chloramphenicol acetyltransferase and resistance determinant described in Enterococcus faecalis | phenicol |
| contig00137 | 161 | 906 | ErmB | 1/1 | 99.9 | 99.6 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00003 | 56772 | 58250 | msrC | 0/0 | 100.0 | 94.4 | AF313494:0-1479 | msrC is a chromosomal-encoded ABC-F subfamily protein expressed in Enterococcus faecium that confers resistance to erythromycin and other macrolide and streptogramin B antibiotics. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00021 | 22046 | 23965 | tetM | 0/0 | 100.0 | 100.0 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| contig00123 | 728 | 1045 | tetU | 0/0 | 100.0 | 99.4 | U01917.1:412-730 | Tetracycline-resistant determinant encoded on the plasmid pKQ10 in Enterococcus faecium | tetracycline |
| contig00097 | 3054 | 4085 | vanA | 0/0 | 100.0 | 100.0 | M97297:6979-8010 | VanA is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Lac an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It has been isolated from VREs. It is associated with both vancomycin and teicoplanin resistance. | glycopeptide |
| contig00097 | 2093 | 3061 | vanHA | 0/0 | 100.0 | 100.0 | M97297:6018-6986 | vanHA also known as vanH is a vanH variant in the vanA gene cluster | glycopeptide |
| contig00097 | 51 | 746 | vanRA | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | vanRA also known as vanR is a vanR variant found in the vanA gene cluster | glycopeptide |
| contig00097 | 724 | 1878 | vanSA | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | vanSA also known as vanS is a vanS variant found in the vanA gene cluster | glycopeptide |
| contig00097 | 4091 | 4699 | vanXA | 0/0 | 100.0 | 100.0 | M97297:8016-8624 | vanXA also known as vanX is a vanX variant found in the vanA gene cluster | glycopeptide |
| contig00112 | 1930 | 2841 | vanYA | 0/0 | 100.0 | 100.0 | M97297:9052-9963 | vanYA also known as vanY is a vanY variant found in the vanA gene cluster | glycopeptide |
| contig00112 | 1292 | 1777 | vanZA | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | vanZA also known as vanZ is a vanZ variant found in the vanA gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00014 | 38383 | 38931 | (AGly)aac6-Ii | 0/0 | 100 | 98.9 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00108 | 2185 | 3093 | (AGly)ant6-Ia | 0/0 | 100 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00097 | 3054 | 4085 | (Gly)vanA-A | 0/0 | 100 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00097 | 2093 | 3061 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00097 | 51 | 746 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00097 | 724 | 1878 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00097 | 4091 | 4699 | (Gly)vanX-A | 0/0 | 100 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00112 | 1930 | 2841 | (Gly)vanY-A | 0/0 | 100 | 100.0 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00112 | 1292 | 1777 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00137 | 161 | 898 | (MLS)erm(B) | 0/0 | 100 | 99.5 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 56772 | 58250 | (MLS)msr(C) | 0/0 | 100 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| contig00080 | 4495 | 5142 | (Phe)cat-pC221 | 0/0 | 100 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00021 | 22046 | 23965 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00123 | 728 | 1045 | (Tet)tetU | 0/0 | 100 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00070 | 4109 | 4604 | (Tmt)dfrF | 1/1 | 100 | 99.6 | NG_047755:101-595 | (Tmt)dfrF | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00014 | 38383 | 38931 | (AGly)aac6-Ii | 0/0 | 100 | 98.9 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00108 | 2185 | 3093 | (AGly)ant6-Ia | 0/0 | 100 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00097 | 3054 | 4085 | (Gly)vanA-A | 0/0 | 100 | 100.0 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00097 | 2093 | 3061 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00097 | 51 | 746 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00097 | 724 | 1878 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00097 | 4091 | 4699 | (Gly)vanX-A | 0/0 | 100 | 100.0 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00112 | 1930 | 2841 | (Gly)vanY-A | 0/0 | 100 | 100.0 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00112 | 1292 | 1777 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00137 | 161 | 898 | (MLS)erm(B) | 0/0 | 100 | 99.5 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 56772 | 58250 | (MLS)msr(C) | 0/0 | 100 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| contig00080 | 4495 | 5142 | (Phe)cat-pC221 | 0/0 | 100 | 97.7 | X02529:2267-2914 | (Phe)cat-pC221 | NA |
| contig00021 | 22046 | 23965 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00123 | 728 | 1045 | (Tet)tetU | 0/0 | 100 | 99.4 | U01917:413-730 | (Tet)tetU | NA |
| contig00070 | 4109 | 4604 | (Tmt)dfrF | 1/1 | 100 | 99.6 | NG_047755:101-595 | (Tmt)dfrF | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00014 | 38383 | 38931 | AAC6-PRIME | 0/0 | 100 | 99.6 | MEG_139 | Drugs:Aminoglycosides:Aminoglycoside_N-acetyltransferases:AAC6-PRIME | NA |
| contig00108 | 2185 | 3093 | ANT6 | 0/0 | 100 | 100.0 | MEG_994 | Drugs:Aminoglycosides:Aminoglycoside_O-nucleotidyltransferases:ANT6 | NA |
| contig00080 | 4495 | 5142 | CATA | 0/0 | 100 | 100.0 | MEG_1591 | Drugs:Phenicol:Chloramphenicol_acetyltransferases:CATA | NA |
| contig00070 | 4109 | 4604 | DFRF | 1/1 | 100 | 99.6 | MEG_2578 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRF | NA |
| contig00006 | 37430 | 38716 | EFMA | 0/0 | 100 | 100.0 | MEG_2704 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_MFS_efflux_pumps:EFMA | NA |
| contig00137 | 136 | 898 | ERMB | 1/1 | 100 | 99.0 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00003 | 56772 | 58250 | MSRC | 0/0 | 100 | 98.9 | MEG_4071 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:MSRC | NA |
| contig00021 | 22046 | 23965 | TETM | 0/0 | 100 | 100.0 | MEG_7145 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| contig00123 | 728 | 1045 | TETU | 0/0 | 100 | 99.4 | MEG_7204 | Drugs:Tetracyclines:Tetracycline_resistance_MFS_efflux_regulator:TETU | NA |
| contig00097 | 2093 | 4699 | VANHA | 0/0 | 100 | 100.0 | MEG_7410 | Drugs:Glycopeptides:VanA-type_resistance_protein:VANHA | NA |
| contig00097 | 51 | 746 | VANRA | 0/0 | 100 | 100.0 | MEG_7453 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00097 | 724 | 1878 | VANRA | 0/0 | 100 | 100.0 | MEG_7454 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00112 | 1292 | 1777 | VANRA | 0/0 | 100 | 100.0 | MEG_7452 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00112 | 1930 | 2841 | VANRA | 0/0 | 100 | 100.0 | MEG_7458 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 57049 | 58545 | lsa(A)_1 | 0/0 | 100 | 99.4 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00031 | 524 | 2464 | tet(S)_3 | 0/0 | 100 | 99.9 | X92946 | tet(S) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00002 | 72187 | 72681 | dfrE | 0/0 | 100.0 | 97.6 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00013 | 35717 | 37444 | efrA | 0/0 | 100.0 | 99.2 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00013 | 38003 | 39056 | efrB | 6/6 | 96.7 | 97.6 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00004 | 173480 | 174634 | emeA | 1/27 | 97.7 | 96.9 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00008 | 57049 | 58545 | lsaA | 0/0 | 100.0 | 99.4 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00031 | 524 | 2449 | tetS | 0/0 | 100.0 | 100.0 | L09756:0-1926 | Tet(S) is a ribosomal protection protein found in Gram-positive and Gram-negative strains. It is similar to tet(M) and tet(O). | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 57049 | 58545 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00002 | 408745 | 409578 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00031 | 524 | 2449 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00002 | 72187 | 72681 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 57049 | 58545 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00002 | 408745 | 409578 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00031 | 524 | 2449 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00002 | 72187 | 72681 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00002 | 72187 | 72681 | DFRE | 0/0 | 100.0 | 97.6 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00013 | 35924 | 37358 | EFRA | 1/1 | 98.5 | 99.0 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00013 | 38003 | 39056 | EFRB | 6/6 | 96.7 | 97.6 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00008 | 57049 | 58545 | LSA | 0/0 | 100.0 | 99.4 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00031 | 524 | 2464 | TETS | 0/0 | 100.0 | 99.9 | MEG_7200 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETS | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00018 | 36401 | 36898 | dfrG_1 | 0/0 | 100 | 100.0 | AB205645 | dfrG | Trimethoprim |
| contig00018 | 43312 | 44074 | erm(B)_18 | 1/1 | 100 | 99.6 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00029 | 796 | 2736 | tet(S)_3 | 0/0 | 100 | 99.9 | X92946 | tet(S) | Doxycycline, Tetracycline, Minocycline |
| contig00012 | 20441 | 22041 | VanC1XY_1 | 0/0 | 100 | 99.9 | AF162694 | VanC1XY | Vancomycin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00018 | 36401 | 36898 | dfrG | 0/0 | 100.0 | 100.0 | AB205645:1012-1510 | dfrG is a plasmid-encoded dihydrofolate reductase found in Staphylococcus aureus | diaminopyrimidine |
| contig00018 | 43304 | 44049 | ErmB | 1/1 | 99.9 | 99.1 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00029 | 796 | 2721 | tetS | 0/0 | 100.0 | 100.0 | L09756:0-1926 | Tet(S) is a ribosomal protection protein found in Gram-positive and Gram-negative strains. It is similar to tet(M) and tet(O). | tetracycline |
| contig00012 | 21010 | 22041 | vanC | 0/0 | 100.0 | 99.8 | AF162694:1410-2442 | VanC is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Ser an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It is specific to Enterococcus gallinarum and E. casseliflavus providing intrinsic resistance. | glycopeptide |
| contig00012 | 17564 | 18259 | vanRC | 0/0 | 100.0 | 100.0 | AF162694:5192-5888 | vanRC is a vanR variant found in the vanC gene cluster | glycopeptide |
| contig00012 | 16489 | 17574 | vanSC | 0/0 | 100.0 | 99.9 | AF162694:5877-6963 | vanSC is a vanS variant found in the vanC gene cluster | glycopeptide |
| contig00012 | 18348 | 20444 | vanTC | 0/0 | 100.0 | 99.9 | AF162694:3007-5104 | vanTC is a vanT variant found in the vanC gene cluster | glycopeptide |
| contig00012 | 20441 | 21013 | vanXYC | 0/0 | 100.0 | 100.0 | AF162694:2438-3011 | vanXYC is a vanXY variant found in the vanC gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00012 | 21010 | 22041 | (Gly)vanC | 0/0 | 100 | 99.8 | AF162694:1411-2442 | (Gly)vanC | NA |
| contig00012 | 17564 | 18259 | (Gly)vanR-C | 0/0 | 100 | 100.0 | AF162694:5193-5888 | (Gly)vanR-C | NA |
| contig00012 | 16489 | 17574 | (Gly)vanS-C | 0/0 | 100 | 99.4 | DQ022190:4672-5757 | (Gly)vanS-C | NA |
| contig00012 | 18348 | 20444 | (Gly)vanT | 0/0 | 100 | 99.9 | AF162694:3008-5104 | (Gly)vanT | NA |
| contig00012 | 20441 | 21013 | (Gly)vanX-Yc | 0/0 | 100 | 100.0 | DQ022190:1233-1805 | (Gly)vanX-Yc | NA |
| contig00018 | 43312 | 44049 | (MLS)erm(B) | 0/0 | 100 | 100.0 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00029 | 796 | 2721 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00018 | 36401 | 36898 | (Tmt)dfrG | 0/0 | 100 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00012 | 21010 | 22041 | (Gly)vanC | 0/0 | 100 | 99.8 | AF162694:1411-2442 | (Gly)vanC | NA |
| contig00012 | 17564 | 18259 | (Gly)vanR-C | 0/0 | 100 | 100.0 | AF162694:5193-5888 | (Gly)vanR-C | NA |
| contig00012 | 16489 | 17574 | (Gly)vanS-C | 0/0 | 100 | 99.4 | DQ022190:4672-5757 | (Gly)vanS-C | NA |
| contig00012 | 18348 | 20444 | (Gly)vanT | 0/0 | 100 | 99.9 | AF162694:3008-5104 | (Gly)vanT | NA |
| contig00012 | 20441 | 21013 | (Gly)vanX-Yc | 0/0 | 100 | 100.0 | DQ022190:1233-1805 | (Gly)vanX-Yc | NA |
| contig00018 | 43312 | 44049 | (MLS)erm(B) | 0/0 | 100 | 100.0 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00029 | 796 | 2721 | (Tet)tetS | 0/0 | 100 | 100.0 | L09756:447-2372 | (Tet)tetS | NA |
| contig00018 | 36401 | 36898 | (Tmt)dfrG | 0/0 | 100 | 100.0 | AB205645:1013-1510 | (Tmt)dfrG | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00018 | 36401 | 36898 | DFRG | 0/0 | 100 | 100.0 | MEG_2579 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRG | NA |
| contig00018 | 43312 | 44074 | ERMB | 1/1 | 100 | 99.6 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00029 | 796 | 2736 | TETS | 0/0 | 100 | 99.9 | MEG_7200 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETS | NA |
| contig00012 | 20441 | 22041 | VANC | 0/0 | 100 | 99.9 | MEG_7373 | Drugs:Glycopeptides:VanC-type_resistance_protein:VANC | NA |
| contig00012 | 16489 | 17574 | VANSC | 0/0 | 100 | 99.9 | MEG_7502 | Drugs:Glycopeptides:VanC-type_regulator:VANSC | NA |
| contig00012 | 17564 | 18259 | VANXYC | 0/0 | 100 | 100.0 | MEG_7584 | Drugs:Glycopeptides:VanC-type_resistance_protein:VANXYC | NA |
| contig00012 | 18348 | 20444 | VANXYC | 0/0 | 100 | 99.9 | MEG_7583 | Drugs:Glycopeptides:VanC-type_resistance_protein:VANXYC | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00011 | 69778 | 70326 | aac(6’)-Ii_1 | 0/0 | 100 | 98.5 | L12710 | aac(6’)-Ii | Amikacin, Tobramycin |
| contig00019 | 42610 | 44088 | msr(C)_2 | 0/0 | 100 | 99.5 | AF313494 | msr(C) | Erythromycin, Telithromycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00011 | 69778 | 70326 | AAC(6’)-Ii | 0/0 | 100 | 98.5 | L12710:0-549 | AAC(6’)-Ii is a chromosomal-encoded aminoglycoside acetyltransferase in Enterococcus spp. | aminoglycoside |
| contig00019 | 42610 | 44088 | msrC | 0/0 | 100 | 99.5 | AF313494:0-1479 | msrC is a chromosomal-encoded ABC-F subfamily protein expressed in Enterococcus faecium that confers resistance to erythromycin and other macrolide and streptogramin B antibiotics. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00011 | 69778 | 70326 | (AGly)aac6-Ii | 0/0 | 100 | 98.5 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00019 | 42610 | 44088 | (MLS)msr(C) | 0/0 | 100 | 95.3 | AY004350:496-1974 | (MLS)msr(C) | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00011 | 69778 | 70326 | (AGly)aac6-Ii | 0/0 | 100 | 98.5 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00019 | 42610 | 44088 | (MLS)msr(C) | 0/0 | 100 | 95.3 | AY004350:496-1974 | (MLS)msr(C) | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00011 | 69778 | 70326 | AAC6-PRIME | 0/0 | 100 | 100.0 | MEG_139 | Drugs:Aminoglycosides:Aminoglycoside_N-acetyltransferases:AAC6-PRIME | NA |
| contig00019 | 42610 | 44088 | MSRC | 0/0 | 100 | 99.5 | MEG_4072 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:MSRC | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 103653 | 105149 | lsa(A)_1 | 0/0 | 100 | 99.4 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00006 | 124979 | 126898 | tet(M)_13 | 0/0 | 100 | 99.9 | AM990992 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 182045 | 182539 | dfrE | 0/0 | 100.0 | 97.6 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00012 | 25123 | 26850 | efrA | 0/0 | 100.0 | 99.3 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00012 | 23511 | 24564 | efrB | 6/6 | 96.7 | 97.6 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00005 | 173315 | 174469 | emeA | 1/27 | 97.7 | 97.0 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00008 | 103653 | 105149 | lsaA | 0/0 | 100.0 | 99.4 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00006 | 124979 | 126898 | tetM | 0/0 | 100.0 | 99.9 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 103653 | 105149 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 490345 | 491178 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00006 | 124979 | 126898 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 182045 | 182539 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00008 | 103653 | 105149 | (MLS)lsa(A) | 0/0 | 100 | 99.4 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00001 | 490345 | 491178 | (MLS)mph(D) | 0/0 | 100 | 99.6 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00006 | 124979 | 126898 | (Tet)tetM | 0/0 | 100 | 99.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 182045 | 182539 | (Tmt)dfrE | 0/0 | 100 | 97.6 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 182045 | 182539 | DFRE | 0/0 | 100.0 | 97.6 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00012 | 25209 | 26643 | EFRA | 1/1 | 98.5 | 99.1 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00012 | 23511 | 24564 | EFRB | 6/6 | 96.7 | 97.6 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00008 | 103653 | 105149 | LSA | 0/0 | 100.0 | 99.4 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00006 | 124979 | 126898 | TETM | 0/0 | 100.0 | 99.9 | MEG_7145 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00027 | 2516 | 3278 | erm(B)_18 | 1/1 | 100 | 99.2 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00003 | 100902 | 102398 | lsa(A)_1 | 0/0 | 100 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00002 | 94583 | 96502 | tet(M)_10 | 0/0 | 100 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00015 | 7680 | 9407 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00015 | 9966 | 11019 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 518638 | 519792 | emeA | 1/27 | 97.7 | 97.4 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00027 | 2541 | 3286 | ErmB | 1/1 | 99.9 | 99.5 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00003 | 100902 | 102398 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00002 | 94583 | 96502 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00027 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100902 | 102398 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 94583 | 96502 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00027 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100902 | 102398 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 94583 | 96502 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00015 | 7887 | 9321 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00015 | 9966 | 11019 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00027 | 2516 | 3278 | ERMB | 1/1 | 100.0 | 99.2 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00003 | 100902 | 102398 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00002 | 94583 | 96502 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00021 | 31437 | 31985 | aac(6’)-Ii_1 | 0/0 | 100 | 99.6 | L12710 | aac(6’)-Ii | Amikacin, Tobramycin |
| contig00107 | 6381 | 7289 | ant(6)-Ia_1 | 0/0 | 100 | 100.0 | AF330699 | ant(6)-Ia | Streptomycin |
| contig00107 | 7921 | 8715 | aph(3’)-III_1 | 0/0 | 100 | 100.0 | M26832 | aph(3’)-III | Amikacin |
| contig00002 | 100972 | 102468 | lsa(A)_1 | 0/0 | 100 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00012 | 80444 | 81922 | msr(C)_1 | 0/0 | 100 | 98.9 | AY004350 | msr(C) | Erythromycin, Telithromycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00005 | 147681 | 149600 | tet(M)_10 | 0/0 | 100 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| contig00115 | 4892 | 7498 | VanHAX_2 | 0/0 | 100 | 99.9 | M97297 | VanHAX | Vancomycin, Teicoplanin |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00021 | 31437 | 31985 | AAC(6’)-Ii | 0/0 | 100.0 | 99.6 | L12710:0-549 | AAC(6’)-Ii is a chromosomal-encoded aminoglycoside acetyltransferase in Enterococcus spp. | aminoglycoside |
| contig00107 | 6459 | 7289 | aad(6) | 0/0 | 100.0 | 100.0 | AY712687:0-831 | aad(6) is a plasmid-encoded aminoglycoside nucleotidyltransferase gene in E. faecalis and Streptococcus oralis | aminoglycoside |
| contig00107 | 7921 | 8715 | APH(3’)-IIIa | 0/0 | 100.0 | 100.0 | CP004067:52914-53709 | APH(3’)-IIIa is a plasmid-encoded aminoglycoside phosphotransferase in S. aureus and Enterococcus spp. | aminoglycoside |
| contig00001 | 77924 | 78418 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00017 | 38939 | 40225 | efmA | 0/0 | 100.0 | 100.0 | AB467372.1:284-1571 | efmA is an MFS transporter permease in E. faecium. | fluoroquinolone, macrolide |
| contig00044 | 7680 | 9407 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00044 | 9966 | 11019 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 519114 | 520268 | emeA | 1/27 | 97.7 | 97.4 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00002 | 100972 | 102468 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00012 | 80444 | 81922 | msrC | 0/0 | 100.0 | 94.4 | AF313494:0-1479 | msrC is a chromosomal-encoded ABC-F subfamily protein expressed in Enterococcus faecium that confers resistance to erythromycin and other macrolide and streptogramin B antibiotics. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00107 | 7286 | 7828 | SAT-4 | 0/0 | 100.0 | 99.8 | U01945:373-916 | SAT-4 is a plasmid-mediated streptothricin acetyltransferase and streptothricin (a nucleoside antibiotic) resistant determinant. Originally described from a Campylobacter coli BE/G4 plasmid gene sequence by Jacob et al 1994. | nucleoside |
| contig00005 | 147681 | 149600 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| contig00115 | 5506 | 6537 | vanA | 0/0 | 100.0 | 99.9 | M97297:6979-8010 | VanA is a D-Ala-D-Ala ligase homolog that synthesizes D-Ala-D-Lac an alternative substrate for peptidoglycan synthesis that reduces vancomycin binding affinity. It has been isolated from VREs. It is associated with both vancomycin and teicoplanin resistance. | glycopeptide |
| contig00115 | 6530 | 7498 | vanHA | 0/0 | 100.0 | 100.0 | M97297:6018-6986 | vanHA also known as vanH is a vanH variant in the vanA gene cluster | glycopeptide |
| contig00115 | 8845 | 9540 | vanRA | 0/0 | 100.0 | 100.0 | M97297:3976-4671 | vanRA also known as vanR is a vanR variant found in the vanA gene cluster | glycopeptide |
| contig00115 | 7713 | 8867 | vanSA | 0/0 | 100.0 | 100.0 | M97297:4649-5803 | vanSA also known as vanS is a vanS variant found in the vanA gene cluster | glycopeptide |
| contig00115 | 4892 | 5500 | vanXA | 0/0 | 100.0 | 99.8 | M97297:8016-8624 | vanXA also known as vanX is a vanX variant found in the vanA gene cluster | glycopeptide |
| contig00115 | 3553 | 4464 | vanYA | 0/0 | 100.0 | 99.8 | M97297:9052-9963 | vanYA also known as vanY is a vanY variant found in the vanA gene cluster | glycopeptide |
| contig00115 | 2915 | 3400 | vanZA | 0/0 | 100.0 | 100.0 | M97297:10116-10601 | vanZA also known as vanZ is a vanZ variant found in the vanA gene cluster | glycopeptide |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00021 | 31437 | 31985 | (AGly)aac6-Ii | 0/0 | 100 | 99.6 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00107 | 6381 | 7289 | (AGly)ant6-Ia | 0/0 | 100 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00107 | 7921 | 8715 | (AGly)aph(3’’)-III | 0/0 | 100 | 100.0 | V01547:535-1329 | (AGly)aph(3’’)-III | NA |
| contig00107 | 7286 | 7828 | (AGly)sat4A | 0/0 | 100 | 100.0 | X92945:38870-39412 | (AGly)sat4A | NA |
| contig00115 | 5506 | 6537 | (Gly)vanA-A | 0/0 | 100 | 99.9 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00115 | 6530 | 7498 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00115 | 8845 | 9540 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00115 | 7713 | 8867 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00115 | 4892 | 5500 | (Gly)vanX-A | 0/0 | 100 | 99.8 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00115 | 3553 | 4464 | (Gly)vanY-A | 0/0 | 100 | 99.8 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00115 | 2915 | 3400 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00002 | 100972 | 102468 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00012 | 80444 | 81922 | (MLS)msr(C) | 0/0 | 100 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| contig00005 | 147681 | 149600 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77924 | 78418 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00021 | 31437 | 31985 | (AGly)aac6-Ii | 0/0 | 100 | 99.6 | L12710:169-717 | (AGly)aac6-Ii | NA |
| contig00107 | 6381 | 7289 | (AGly)ant6-Ia | 0/0 | 100 | 100.0 | AF330699:22-930 | (AGly)ant6-Ia | NA |
| contig00107 | 7921 | 8715 | (AGly)aph(3’’)-III | 0/0 | 100 | 100.0 | V01547:535-1329 | (AGly)aph(3’’)-III | NA |
| contig00107 | 7286 | 7828 | (AGly)sat4A | 0/0 | 100 | 100.0 | X92945:38870-39412 | (AGly)sat4A | NA |
| contig00115 | 5506 | 6537 | (Gly)vanA-A | 0/0 | 100 | 99.9 | M97297:6979-8010 | (Gly)vanA-A | NA |
| contig00115 | 6530 | 7498 | (Gly)vanH-A | 0/0 | 100 | 100.0 | FJ866609:3762-4730 | (Gly)vanH-A | NA |
| contig00115 | 8845 | 9540 | (Gly)vanR-A | 0/0 | 100 | 100.0 | M97297:3976-4671 | (Gly)vanR-A | NA |
| contig00115 | 7713 | 8867 | (Gly)vanS-A | 0/0 | 100 | 100.0 | M97297:4649-5803 | (Gly)vanS-A | NA |
| contig00115 | 4892 | 5500 | (Gly)vanX-A | 0/0 | 100 | 99.8 | M97297:8016-8624 | (Gly)vanX-A | NA |
| contig00115 | 3553 | 4464 | (Gly)vanY-A | 0/0 | 100 | 99.8 | M97297:9052-9963 | (Gly)vanY-A | NA |
| contig00115 | 2915 | 3400 | (Gly)vanZ-A | 0/0 | 100 | 100.0 | M97297:10116-10601 | (Gly)vanZ-A | NA |
| contig00002 | 100972 | 102468 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00012 | 80444 | 81922 | (MLS)msr(C) | 0/0 | 100 | 98.9 | AY004350:496-1974 | (MLS)msr(C) | NA |
| contig00005 | 147681 | 149600 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77924 | 78418 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00021 | 31437 | 31985 | AAC6-PRIME | 0/0 | 100.0 | 100.0 | MEG_84 | Drugs:Aminoglycosides:Aminoglycoside_N-acetyltransferases:AAC6-PRIME | NA |
| contig00107 | 6381 | 7289 | ANT6 | 0/0 | 100.0 | 100.0 | MEG_994 | Drugs:Aminoglycosides:Aminoglycoside_O-nucleotidyltransferases:ANT6 | NA |
| contig00107 | 7921 | 8715 | APH2-DPRIME | 0/0 | 100.0 | 100.0 | MEG_1016 | Drugs:Aminoglycosides:Aminoglycoside_O-phosphotransferases:APH2-DPRIME | NA |
| contig00001 | 77924 | 78418 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00017 | 38939 | 40225 | EFMA | 0/0 | 100.0 | 100.0 | MEG_2704 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_MFS_efflux_pumps:EFMA | NA |
| contig00044 | 7887 | 9321 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00044 | 9966 | 11019 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00002 | 100972 | 102468 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00012 | 80444 | 81922 | MSRC | 0/0 | 100.0 | 98.9 | MEG_4071 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:MSRC | NA |
| contig00107 | 7286 | 7828 | SAT | 0/0 | 100.0 | 100.0 | MEG_6166 | Drugs:Nucleosides:Streptothricin_acetyltransferase:SAT | NA |
| contig00005 | 147681 | 149600 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| contig00115 | 4892 | 7498 | VANHA | 0/0 | 100.0 | 99.9 | MEG_7410 | Drugs:Glycopeptides:VanA-type_resistance_protein:VANHA | NA |
| contig00115 | 2915 | 3400 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7452 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00115 | 3553 | 4464 | VANRA | 0/0 | 100.0 | 99.8 | MEG_7458 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00115 | 7713 | 8867 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7454 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| contig00115 | 8845 | 9540 | VANRA | 0/0 | 100.0 | 100.0 | MEG_7453 | Drugs:Glycopeptides:VanA-type_regulator:VANRA | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00028 | 2516 | 3278 | erm(B)_18 | 1/1 | 100 | 99.2 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00003 | 100982 | 102478 | lsa(A)_1 | 0/0 | 100 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00002 | 94435 | 96354 | tet(M)_10 | 0/0 | 100 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00017 | 7680 | 9407 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00017 | 9966 | 11019 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 518638 | 519792 | emeA | 1/27 | 97.7 | 97.4 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00028 | 2541 | 3286 | ErmB | 1/1 | 99.9 | 99.5 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00003 | 100982 | 102478 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00002 | 94435 | 96354 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00028 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100982 | 102478 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 94435 | 96354 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00028 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100982 | 102478 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 94435 | 96354 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00017 | 7887 | 9321 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00017 | 9966 | 11019 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00028 | 2516 | 3278 | ERMB | 1/1 | 100.0 | 99.2 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00003 | 100982 | 102478 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00002 | 94435 | 96354 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00025 | 2516 | 3278 | erm(B)_18 | 1/1 | 100 | 99.2 | X66468 | erm(B) | Erythromycin, Lincomycin, Clindamycin, Quinupristin, Pristinamycin_IA, Virginiamycin_S |
| contig00003 | 100981 | 102477 | lsa(A)_1 | 0/0 | 100 | 98.9 | AY225127 | lsa(A) | Lincomycin, Clindamycin, Dalfopristin, Pristinamycin_IIA, Virginiamycin_M |
| contig00002 | 92923 | 94842 | tet(M)_10 | 0/0 | 100 | 100.0 | EU182585 | tet(M) | Doxycycline, Tetracycline, Minocycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | dfrE | 0/0 | 100.0 | 97.4 | AIIS01000002.1:234307-233812 | dfrE is a chromosome-encoded dihydrofolate reductase found in Enterococcus faecalis | diaminopyrimidine |
| contig00015 | 7680 | 9407 | efrA | 0/0 | 100.0 | 98.9 | NZ_PTWF01000025.1:35858-37586 | efrA is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer drug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00015 | 9966 | 11019 | efrB | 6/6 | 96.7 | 97.5 | HG970103.1:0-1086 | efrB is a part of the EfrAB efflux pump and both efrA and efrB are necessary to confer multidrug resistance. | fluoroquinolone, macrolide, rifamycin |
| contig00001 | 518638 | 519792 | emeA | 1/27 | 97.7 | 97.4 | AB091338:173-1355 | A multidrug efflux pump from Enterococcus faecalis. There exist efflux activity of several antimicrobial agents such as DAPI Hoechst 33342 and acriflavine. Efflux of DAPI via EmeA was strongly inhibited by reserpine. | acridine_dye |
| contig00025 | 2541 | 3286 | ErmB | 1/1 | 99.9 | 99.5 | AF242872.1:2131-2878 | ErmB confers the MLSb phenotype. Similar to ErmC expression of ErmB is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present it binds the leader peptide causing a change in conformation allowing for the expression of ErmB. | lincosamide, macrolide, streptogramin |
| contig00003 | 100981 | 102477 | lsaA | 0/0 | 100.0 | 98.9 | AY225127.1:40-1537 | LsaA is an ABC-F subfamily protein expressed in Enterococcus faecalis. It confers resistance to clindamycin quinupristin-dalfopristin and dalfopristin. | lincosamide, macrolide, oxazolidinone, phenicol, pleuromutilin, streptogramin, tetracycline |
| contig00002 | 92923 | 94842 | tetM | 0/0 | 100.0 | 94.4 | AM990992.1:1003680-1001760 | TetM is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented. | tetracycline |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00025 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100981 | 102477 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 92923 | 94842 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00025 | 2541 | 3278 | (MLS)erm(B) | 0/0 | 100 | 99.6 | M11180:714-1451 | (MLS)erm(B) | NA |
| contig00003 | 100981 | 102477 | (MLS)lsa(A) | 0/0 | 100 | 98.9 | AY225127:41-1537 | (MLS)lsa(A) | NA |
| contig00010 | 40387 | 41220 | (MLS)mph(D) | 0/0 | 100 | 99.9 | NC_017312:2291580-2292413 | (MLS)mph(D) | NA |
| contig00002 | 92923 | 94842 | (Tet)tetM | 0/0 | 100 | 94.2 | DQ534550:1451-3370 | (Tet)tetM | NA |
| contig00001 | 77448 | 77942 | (Tmt)dfrE | 0/0 | 100 | 97.4 | NG_055770:101-595 | (Tmt)dfrE | NA |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product | Resistance |
|---|---|---|---|---|---|---|---|---|---|
| contig00001 | 77448 | 77942 | DFRE | 0/0 | 100.0 | 97.4 | MEG_2577 | Drugs:Trimethoprim:Dihydrofolate_reductase:DFRE | NA |
| contig00015 | 7887 | 9321 | EFRA | 1/1 | 98.5 | 98.8 | MEG_2706 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRA | NA |
| contig00015 | 9966 | 11019 | EFRB | 6/6 | 96.7 | 97.5 | MEG_2707 | Multi-compound:Drug_and_biocide_resistance:Drug_and_biocide_ABC_efflux_pumps:EFRB | NA |
| contig00025 | 2516 | 3278 | ERMB | 1/1 | 100.0 | 99.2 | MEG_2801 | Drugs:MLS:23S_rRNA_methyltransferases:ERMB | NA |
| contig00003 | 100981 | 102477 | LSA | 0/0 | 100.0 | 98.9 | MEG_3644 | Drugs:MLS:MLS_resistance_ABC_efflux_pumps:LSA | NA |
| contig00002 | 92923 | 94842 | TETM | 0/0 | 100.0 | 100.0 | MEG_7144 | Drugs:Tetracyclines:Tetracycline_resistance_ribosomal_protection_proteins:TETM | NA |
Presence/Absence of antibiotic resistance genes (coverage and identity > 90%) on each sample
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00026 | 2151 | 3161 | rep9a_1_repA(pAD1) | 0/0 | 100 | 96.0 | L01794 | rep9a_1_repA(pAD1)_L01794 |
| contig00022 | 10809 | 11816 | rep9b_3_repA(pMG2200) | 0/0 | 100 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00013 | 55553 | 56554 | rep9c_2_prgW(pCF10) | 0/0 | 100 | 96.5 | AY855841 | rep9c_2_prgW(pCF10)_AY855841 |
| contig00002 | 42100 | 43305 | repUS43_1_CDS12738(DOp1) | 0/0 | 100 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00028 | 6614 | 8104 | rep1_1_repE(pAMbeta) | 0/0 | 100.0 | 100.0 | AF007787 | rep1_1_repE(pAMbeta)_AF007787 |
| contig00031 | 5273 | 6129 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00045 | 731 | 1744 | rep14a_4_rep(AUS0004p3) | 0/0 | 98.8 | 92.1 | CP003354 | rep14a_4_rep(AUS0004p3)_CP003354 |
| contig00029 | 6028 | 7521 | rep2_1_orf1(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep2_1_orf1(pRE25)_X92945 |
| contig00028 | 2119 | 3057 | rep7a_8_ORF11(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep7a_8_ORF11(pRE25)_X92945 |
| contig00019 | 6111 | 7121 | rep9a_1_repA(pAD1) | 0/0 | 100.0 | 96.0 | L01794 | rep9a_1_repA(pAD1)_L01794 |
| contig00007 | 115500 | 116705 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 99.9 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00033 | 1494 | 2984 | rep1_1_repE(pAMbeta) | 0/0 | 100.0 | 100.0 | AF007787 | rep1_1_repE(pAMbeta)_AF007787 |
| contig00029 | 5117 | 6061 | rep11a_1_repA(pB82) | 0/0 | 100.0 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00046 | 731 | 1744 | rep14a_4_rep(AUS0004p3) | 0/0 | 98.8 | 92.1 | CP003354 | rep14a_4_rep(AUS0004p3)_CP003354 |
| contig00039 | 489 | 1427 | rep7a_8_ORF11(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep7a_8_ORF11(pRE25)_X92945 |
| contig00030 | 2151 | 3161 | rep9a_1_repA(pAD1) | 0/0 | 100.0 | 96.0 | L01794 | rep9a_1_repA(pAD1)_L01794 |
| contig00025 | 10809 | 11816 | rep9b_3_repA(pMG2200) | 0/0 | 100.0 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00014 | 55553 | 56554 | rep9c_2_prgW(pCF10) | 0/0 | 100.0 | 96.5 | AY855841 | rep9c_2_prgW(pCF10)_AY855841 |
| contig00032 | 1447 | 2487 | repUS15_2_repA(pNB2354p1) | 0/0 | 100.0 | 99.8 | CP004064 | repUS15_2_repA(pNB2354p1)_CP004064 |
| contig00002 | 42587 | 43792 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00028 | 3326 | 4048 | rep6_1_repA(pS86) | 0/0 | 100 | 100.0 | AJ223161 | rep6_1_repA(pS86)_AJ223161 |
| contig00018 | 10842 | 11825 | rep8b_1_repA(pEJ97p1) | 0/0 | 100 | 99.9 | AJ49170 | rep8b_1_repA(pEJ97p1)_AJ49170 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00089 | 5317 | 6173 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00106 | 2848 | 3798 | rep14b_3_rep(pRI1) | 0/0 | 100.0 | 100 | EU327398 | rep14b_3_rep(pRI1)_EU327398 |
| contig00070 | 4699 | 5739 | rep17_1_CDS29(pRUM) | 0/0 | 100.0 | 100 | AF507977 | rep17_1_CDS29(pRUM)_AF507977 |
| contig00068 | 8676 | 10169 | rep2_1_orf1(pRE25) | 0/0 | 100.0 | 100 | X92945 | rep2_1_orf1(pRE25)_X92945 |
| contig00084 | 4585 | 5322 | rep29_2_EFAU085p4001(Aus0085p4)_Aus0085 | 0/0 | 100.0 | 100 | rep29_2_EFAU085p4001(Aus0085p4)_Aus0085 | |
| contig00083 | 2016 | 3056 | repUS15_1_repA(DO3) | 0/0 | 100.0 | 100 | CP003586 | repUS15_1_repA(DO3)_CP003586 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00080 | 225 | 1715 | rep1_1_repE(pAMbeta) | 0/0 | 100.0 | 100.0 | AF007787 | rep1_1_repE(pAMbeta)_AF007787 |
| contig00088 | 5317 | 6173 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00123 | 731 | 1744 | rep14a_4_rep(AUS0004p3) | 0/0 | 98.8 | 92.1 | CP003354 | rep14a_4_rep(AUS0004p3)_CP003354 |
| contig00075 | 6028 | 7521 | rep2_1_orf1(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep2_1_orf1(pRE25)_X92945 |
| contig00080 | 5272 | 6210 | rep7a_8_ORF11(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep7a_8_ORF11(pRE25)_X92945 |
| contig00095 | 2092 | 3132 | repUS15_2_repA(pNB2354p1) | 0/0 | 100.0 | 99.8 | CP004064 | repUS15_2_repA(pNB2354p1)_CP004064 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00030 | 3326 | 4048 | rep6_1_repA(pS86) | 0/0 | 100 | 100.0 | AJ223161 | rep6_1_repA(pS86)_AJ223161 |
| contig00019 | 10842 | 11825 | rep8b_1_repA(pEJ97p1) | 0/0 | 100 | 99.9 | AJ49170 | rep8b_1_repA(pEJ97p1)_AJ49170 |
## [1] "NO PLASMID FOUND!!"
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00033 | 5332 | 6188 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00038 | 1065 | 2105 | repUS15_1_repA(DO3) | 0/0 | 100.0 | 99.9 | CP003586 | repUS15_1_repA(DO3)_CP003586 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00027 | 5332 | 6188 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00017 | 6111 | 7121 | rep9a_1_repA(pAD1) | 0/0 | 100.0 | 96.0 | L01794 | rep9a_1_repA(pAD1)_L01794 |
| contig00006 | 115500 | 116705 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 99.9 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00030 | 3327 | 4049 | rep6_1_repA(pS86) | 0/0 | 100.0 | 100.0 | AJ223161 | rep6_1_repA(pS86)_AJ223161 |
| contig00012 | 54082 | 55089 | rep9b_3_repA(pMG2200) | 0/0 | 100.0 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00016 | 18857 | 19861 | rep9c_1_repA(pTW9) | 2/3 | 99.7 | 96.4 | AB563188 | rep9c_1_repA(pTW9)_AB563188 |
| contig00002 | 104776 | 105981 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00141 | 5317 | 6173 | rep11a_1_repA(pB82) | 0/0 | 90.7 | 100.0 | AB178871 | rep11a_1_repA(pB82)_AB178871 |
| contig00163 | 2848 | 3798 | rep14b_3_rep(pRI1) | 0/0 | 100.0 | 100.0 | EU327398 | rep14b_3_rep(pRI1)_EU327398 |
| contig00110 | 4699 | 5739 | rep17_1_CDS29(pRUM) | 0/0 | 100.0 | 100.0 | AF507977 | rep17_1_CDS29(pRUM)_AF507977 |
| contig00108 | 8676 | 10169 | rep2_1_orf1(pRE25) | 0/0 | 100.0 | 100.0 | X92945 | rep2_1_orf1(pRE25)_X92945 |
| contig00136 | 4585 | 5322 | rep29_2_EFAU085p4001(Aus0085p4)_Aus0085 | 0/0 | 100.0 | 100.0 | rep29_2_EFAU085p4001(Aus0085p4)_Aus0085 | |
| contig00151 | 4237 | 4959 | rep6_1_repA(pS86) | 0/0 | 100.0 | 100.0 | AJ223161 | rep6_1_repA(pS86)_AJ223161 |
| contig00018 | 14859 | 15866 | rep9b_3_repA(pMG2200) | 0/0 | 100.0 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00047 | 12667 | 13671 | rep9c_1_repA(pTW9) | 2/3 | 99.7 | 96.4 | AB563188 | rep9c_1_repA(pTW9)_AB563188 |
| contig00134 | 2016 | 3056 | repUS15_1_repA(DO3) | 0/0 | 100.0 | 100.0 | CP003586 | repUS15_1_repA(DO3)_CP003586 |
| contig00005 | 138202 | 139407 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00012 | 54082 | 55089 | rep9b_3_repA(pMG2200) | 0/0 | 100.0 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00016 | 19925 | 20929 | rep9c_1_repA(pTW9) | 2/3 | 99.7 | 96.4 | AB563188 | rep9c_1_repA(pTW9)_AB563188 |
| contig00002 | 104628 | 105833 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00012 | 54082 | 55089 | rep9b_3_repA(pMG2200) | 0/0 | 100.0 | 100.0 | AB374546 | rep9b_3_repA(pMG2200)_AB374546 |
| contig00016 | 19026 | 20030 | rep9c_1_repA(pTW9) | 2/3 | 99.7 | 96.4 | AB563188 | rep9c_1_repA(pTW9)_AB563188 |
| contig00002 | 103116 | 104321 | repUS43_1_CDS12738(DOp1) | 0/0 | 100.0 | 100.0 | CP003584 | repUS43_1_CDS12738(DOp1)_CP003584 |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00002 | 60574 | 61584 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00003 | 383485 | 384300 | cpsA | 0/0 | 100.0 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 382688 | 383488 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 381046 | 382215 | cpsC | 0/0 | 100.0 | 99.4 | NP_816139 | (cpsC) teichoic acid biosynthesis protein putative [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 379561 | 381027 | cpsD | 0/0 | 100.0 | 98.8 | NP_816138 | (cpsD) glycosyl transferase group 2 family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 376981 | 379491 | cpsE | 0/0 | 100.0 | 99.2 | NP_816137 | (cpsE) glycosyl transferase group 2 family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 376106 | 376957 | cpsF | 0/0 | 100.0 | 99.9 | NP_816136 | (cpsF) CpsF protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 373626 | 376079 | cpsG | 0/0 | 100.0 | 99.4 | NP_816135 | (cpsG) MurB family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 373210 | 373608 | cpsH | 0/0 | 100.0 | 99.8 | NP_816134 | (cpsH) lipoprotein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 372012 | 373151 | cpsI | 0/0 | 100.0 | 100.0 | NP_816133 | (cpsI) UDP-galactopyranose mutase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 370643 | 371986 | cpsJ | 0/0 | 100.0 | 100.0 | NP_816132 | (cpsJ) ABC transporter ATP-binding protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 369831 | 370643 | cpsK | 0/0 | 100.0 | 99.0 | NP_816131 | (cpsK) ABC transporter permease protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00017 | 5642 | 6880 | cylA | 0/0 | 100.0 | 99.4 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 6877 | 9021 | cylB | 0/0 | 100.0 | 99.7 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 4658 | 5641 | cylI | 0/0 | 100.0 | 97.2 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 12300 | 12506 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 9033 | 12014 | cylM | 0/0 | 100.0 | 99.6 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 12625 | 12909 | cylR1 | 0/0 | 100.0 | 98.6 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 12910 | 13110 | cylR2 | 0/0 | 100.0 | 99.5 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00017 | 12075 | 12266 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 508561 | 511872 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 507127 | 508557 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 505247 | 507130 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00013 | 42325 | 46224 | EF0149 | 0/0 | 99.5 | 94.3 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00003 | 55738 | 56664 | efaA | 0/0 | 100.0 | 99.7 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00007 | 116938 | 122901 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00001 | 504309 | 505153 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00006 | 150491 | 152515 | ace | 0/0 | 100 | 96.9 | NP_814829 | (ace) collagen adhesin protein [Ace (VF0355)] [Enterococcus faecalis V583] |
| contig00004 | 101375 | 102385 | bopD | 0/0 | 100 | 99.1 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00002 | 99283 | 100098 | cpsA | 0/0 | 100 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00002 | 98486 | 99286 | cpsB | 0/0 | 100 | 99.5 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 162063 | 165374 | ebpA | 0/0 | 100 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00006 | 160629 | 162059 | ebpB | 0/0 | 100 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00006 | 158749 | 160632 | ebpC | 1/6 | 100 | 99.0 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00003 | 16103 | 19117 | EF0818 | 0/0 | 100 | 99.2 | NP_814561 | (EF0818) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00005 | 42479 | 46597 | EF3023 | 0/0 | 100 | 98.5 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00001 | 557717 | 558643 | efaA | 0/0 | 100 | 99.6 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00001 | 421437 | 422168 | fsrA | 0/0 | 100 | 98.6 | NP_815519 | (fsrA) response regulator [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 420620 | 421348 | fsrB | 0/0 | 100 | 98.8 | NP_815518 | (fsrB) agrBfs protein [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 419280 | 420623 | fsrC | 0/0 | 100 | 99.5 | NP_815517 | (fsrC) histidine kinase putative [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00007 | 2843 | 8806 | fss1 | 0/0 | 100 | 98.7 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00001 | 417513 | 419045 | gelE | 0/0 | 100 | 98.8 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00001 | 416610 | 417464 | sprE | 0/0 | 100 | 98.8 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00006 | 157801 | 158655 | srtC | 0/0 | 100 | 99.2 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00002 | 61061 | 62071 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00006 | 191502 | 192317 | cpsA | 0/0 | 100.0 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 190705 | 191505 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 189063 | 190232 | cpsC | 0/0 | 100.0 | 99.4 | NP_816139 | (cpsC) teichoic acid biosynthesis protein putative [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 187578 | 189044 | cpsD | 0/0 | 100.0 | 98.8 | NP_816138 | (cpsD) glycosyl transferase group 2 family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 184998 | 187508 | cpsE | 0/0 | 100.0 | 99.2 | NP_816137 | (cpsE) glycosyl transferase group 2 family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 184123 | 184974 | cpsF | 0/0 | 100.0 | 99.9 | NP_816136 | (cpsF) CpsF protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 181643 | 184096 | cpsG | 0/0 | 100.0 | 99.4 | NP_816135 | (cpsG) MurB family protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 181227 | 181625 | cpsH | 0/0 | 100.0 | 99.8 | NP_816134 | (cpsH) lipoprotein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 180029 | 181168 | cpsI | 0/0 | 100.0 | 100.0 | NP_816133 | (cpsI) UDP-galactopyranose mutase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 178660 | 180003 | cpsJ | 0/0 | 100.0 | 100.0 | NP_816132 | (cpsJ) ABC transporter ATP-binding protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 177848 | 178660 | cpsK | 0/0 | 100.0 | 99.0 | NP_816131 | (cpsK) ABC transporter permease protein [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00019 | 5642 | 6880 | cylA | 0/0 | 100.0 | 99.4 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 6877 | 9021 | cylB | 0/0 | 100.0 | 99.7 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 4658 | 5641 | cylI | 0/0 | 100.0 | 97.2 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 12300 | 12506 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 9033 | 12014 | cylM | 0/0 | 100.0 | 99.6 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 12625 | 12909 | cylR1 | 0/0 | 100.0 | 98.6 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 12910 | 13110 | cylR2 | 0/0 | 100.0 | 99.5 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00019 | 12075 | 12266 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 33491 | 36802 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 36806 | 38236 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 38233 | 40116 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00014 | 42325 | 46224 | EF0149 | 0/0 | 99.5 | 94.3 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00003 | 124750 | 128612 | EF3023 | 0/0 | 93.8 | 98.7 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00007 | 56246 | 57172 | efaA | 0/0 | 100.0 | 99.7 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00008 | 116938 | 122901 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00001 | 40210 | 41054 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00006 | 147577 | 149601 | ace | 0/0 | 100 | 97.0 | NP_814829 | (ace) collagen adhesin protein [Ace (VF0355)] [Enterococcus faecalis V583] |
| contig00003 | 140001 | 141011 | bopD | 0/0 | 100 | 99.1 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00011 | 20269 | 21084 | cpsA | 0/0 | 100 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00011 | 19472 | 20272 | cpsB | 0/0 | 100 | 99.5 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 159149 | 162460 | ebpA | 0/0 | 100 | 99.4 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00006 | 157715 | 159145 | ebpB | 0/0 | 100 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00006 | 155835 | 157718 | ebpC | 1/6 | 100 | 99.0 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00002 | 16103 | 19117 | EF0818 | 0/0 | 100 | 99.2 | NP_814561 | (EF0818) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00001 | 476710 | 477636 | efaA | 0/0 | 100 | 99.6 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00001 | 311577 | 312308 | fsrA | 0/0 | 100 | 98.6 | NP_815519 | (fsrA) response regulator [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 310760 | 311488 | fsrB | 0/0 | 100 | 98.8 | NP_815518 | (fsrB) agrBfs protein [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 309420 | 310763 | fsrC | 0/0 | 100 | 99.5 | NP_815517 | (fsrC) histidine kinase putative [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00004 | 98319 | 104282 | fss1 | 0/0 | 100 | 98.7 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00001 | 307653 | 309185 | gelE | 0/0 | 100 | 98.8 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00001 | 306750 | 307604 | sprE | 0/0 | 100 | 98.8 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00006 | 154887 | 155741 | srtC | 0/0 | 100 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00010 | 18368 | 20533 | acm | 0/0 | 100.0 | 100.0 | AAN12397 | (acm) collagen adhesin precursor Acm [Acm (VF0419)] [Enterococcus faecium str. TX2555] |
| contig00020 | 23250 | 26421 | fss3 | 0/0 | 98.3 | 90.7 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00048 | 3922 | 4896 | sgrA | 0/0 | 100.0 | 100.0 | ZP_00602747 | (sgrA) cell wall anchored protein SgrA [SgrA (VF0540)] [Enterococcus faecium DO] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00014 | 49159 | 51324 | acm | 0/0 | 100.0 | 96.9 | AAN12397 | (acm) collagen adhesin precursor Acm [Acm (VF0419)] [Enterococcus faecium str. TX2555] |
| contig00034 | 18672 | 21899 | ecbA | 0/0 | 100.0 | 100.0 | ZP_00603098 | (ecbA) Collagen binding MSCRAMM EcbA [EcbA (VF0539)] [Enterococcus faecium DO] |
| contig00003 | 95655 | 98826 | fss3 | 0/0 | 98.3 | 90.7 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00042 | 3783 | 4757 | sgrA | 0/0 | 100.0 | 100.0 | ZP_00602747 | (sgrA) cell wall anchored protein SgrA [SgrA (VF0540)] [Enterococcus faecium DO] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00004 | 150656 | 152680 | ace | 0/0 | 100 | 97.0 | NP_814829 | (ace) collagen adhesin protein [Ace (VF0355)] [Enterococcus faecalis V583] |
| contig00001 | 139741 | 140751 | bopD | 0/0 | 100 | 99.1 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00010 | 20269 | 21084 | cpsA | 0/0 | 100 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00010 | 19472 | 20272 | cpsB | 0/0 | 100 | 99.5 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00004 | 162228 | 165539 | ebpA | 0/0 | 100 | 99.4 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00004 | 160794 | 162224 | ebpB | 0/0 | 100 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00004 | 158914 | 160797 | ebpC | 1/6 | 100 | 99.0 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 273341 | 276355 | EF0818 | 0/0 | 100 | 99.2 | NP_814561 | (EF0818) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00002 | 476710 | 477636 | efaA | 0/0 | 100 | 99.6 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00002 | 311577 | 312308 | fsrA | 0/0 | 100 | 98.6 | NP_815519 | (fsrA) response regulator [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00002 | 310760 | 311488 | fsrB | 0/0 | 100 | 98.8 | NP_815518 | (fsrB) agrBfs protein [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00002 | 309420 | 310763 | fsrC | 0/0 | 100 | 99.5 | NP_815517 | (fsrC) histidine kinase putative [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00005 | 5654 | 11617 | fss1 | 0/0 | 100 | 98.7 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00002 | 307653 | 309185 | gelE | 0/0 | 100 | 98.8 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00002 | 306750 | 307604 | sprE | 0/0 | 100 | 98.8 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00004 | 157966 | 158820 | srtC | 0/0 | 100 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
## [1] "NO VIRULENCE FACTORS DETECTED!!!"
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00011 | 80554 | 82734 | acm | 1/15 | 100 | 96.2 | AAN12397 | (acm) collagen adhesin precursor Acm [Acm (VF0419)] [Enterococcus faecium str. TX2555] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00005 | 150491 | 152515 | ace | 0/0 | 100 | 96.9 | NP_814829 | (ace) collagen adhesin protein [Ace (VF0355)] [Enterococcus faecalis V583] |
| contig00002 | 101375 | 102385 | bopD | 0/0 | 100 | 99.1 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00003 | 99283 | 100098 | cpsA | 0/0 | 100 | 99.6 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00003 | 98486 | 99286 | cpsB | 0/0 | 100 | 99.5 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00005 | 162063 | 165374 | ebpA | 0/0 | 100 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00005 | 160629 | 162059 | ebpB | 0/0 | 100 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00005 | 158749 | 160632 | ebpC | 1/6 | 100 | 99.0 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00002 | 234974 | 237988 | EF0818 | 0/0 | 100 | 99.2 | NP_814561 | (EF0818) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00004 | 42444 | 46562 | EF3023 | 0/0 | 100 | 98.5 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00001 | 557717 | 558643 | efaA | 0/0 | 100 | 99.6 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00001 | 421437 | 422168 | fsrA | 0/0 | 100 | 98.6 | NP_815519 | (fsrA) response regulator [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 420620 | 421348 | fsrB | 0/0 | 100 | 98.8 | NP_815518 | (fsrB) agrBfs protein [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00001 | 419280 | 420623 | fsrC | 0/0 | 100 | 99.5 | NP_815517 | (fsrC) histidine kinase putative [Fsr (VF0360)] [Enterococcus faecalis V583] |
| contig00006 | 2843 | 8806 | fss1 | 0/0 | 100 | 98.7 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00001 | 417513 | 419045 | gelE | 0/0 | 100 | 98.8 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00001 | 416610 | 417464 | sprE | 0/0 | 100 | 98.8 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00005 | 157801 | 158655 | srtC | 0/0 | 100 | 99.2 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00002 | 123250 | 124260 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00005 | 194106 | 194921 | cpsA | 0/0 | 100.0 | 99.1 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00005 | 193309 | 194109 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00021 | 7897 | 9135 | cylA | 0/0 | 100.0 | 99.8 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 9132 | 11276 | cylB | 0/0 | 100.0 | 99.8 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 6913 | 7896 | cylI | 0/0 | 100.0 | 97.3 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 14555 | 14761 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 11288 | 14269 | cylM | 0/0 | 100.0 | 99.7 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 14880 | 15164 | cylR1 | 0/0 | 100.0 | 100.0 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 15165 | 15365 | cylR2 | 0/0 | 100.0 | 100.0 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00021 | 14330 | 14521 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 508008 | 511319 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 506574 | 508004 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 504694 | 506577 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00004 | 182154 | 186071 | EF0149 | 0/0 | 100.0 | 100.0 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00009 | 102987 | 106849 | EF3023 | 0/0 | 93.8 | 98.7 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00011 | 39052 | 39978 | efaA | 0/0 | 100.0 | 99.3 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00004 | 131651 | 137614 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00010 | 88814 | 92041 | fss3 | 0/0 | 100.0 | 99.4 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00006 | 155106 | 156638 | gelE | 0/0 | 100.0 | 98.9 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00016 | 29749 | 33666 | prgB/asc10 | 2/4 | 100.0 | 94.7 | NP_817031 | (prgB/asc10) aggregation substance PrgB/Asc10 [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00006 | 154203 | 155057 | sprE | 0/0 | 100.0 | 98.5 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00001 | 503756 | 504600 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00021 | 18371 | 20536 | acm | 0/0 | 100.0 | 100.0 | AAN12397 | (acm) collagen adhesin precursor Acm [Acm (VF0419)] [Enterococcus faecium str. TX2555] |
| contig00005 | 119923 | 120933 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00004 | 194106 | 194921 | cpsA | 0/0 | 100.0 | 99.1 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00004 | 193309 | 194109 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00088 | 6895 | 8133 | cylA | 0/0 | 100.0 | 99.8 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 8130 | 10274 | cylB | 0/0 | 100.0 | 99.8 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 5911 | 6894 | cylI | 0/0 | 100.0 | 97.3 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 13553 | 13759 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 10286 | 13267 | cylM | 0/0 | 100.0 | 99.7 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 13878 | 14162 | cylR1 | 0/0 | 100.0 | 100.0 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 14163 | 14363 | cylR2 | 0/0 | 100.0 | 100.0 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00088 | 13328 | 13519 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 508484 | 511795 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 507050 | 508480 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 505170 | 507053 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00003 | 182144 | 186061 | EF0149 | 0/0 | 100.0 | 100.0 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00018 | 25912 | 29837 | EF0485 | 3/11 | 100.0 | 95.3 | NP_814266 | (EF0485) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00014 | 61954 | 65816 | EF3023 | 0/0 | 93.8 | 98.7 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00015 | 39052 | 39978 | efaA | 0/0 | 100.0 | 99.3 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00003 | 131641 | 137604 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00010 | 88814 | 92041 | fss3 | 0/0 | 100.0 | 99.4 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00035 | 24478 | 27649 | fss3 | 0/0 | 98.3 | 90.7 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00043 | 22144 | 23676 | gelE | 0/0 | 100.0 | 98.9 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00047 | 23559 | 27476 | prgB/asc10 | 2/4 | 100.0 | 94.7 | NP_817031 | (prgB/asc10) aggregation substance PrgB/Asc10 [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00133 | 2479 | 3453 | sgrA | 0/0 | 100.0 | 100.0 | ZP_00602747 | (sgrA) cell wall anchored protein SgrA [SgrA (VF0540)] [Enterococcus faecium DO] |
| contig00043 | 21241 | 22095 | sprE | 0/0 | 100.0 | 98.5 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00001 | 504232 | 505076 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00002 | 123102 | 124112 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00005 | 194106 | 194921 | cpsA | 0/0 | 100.0 | 99.1 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00005 | 193309 | 194109 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00024 | 7897 | 9135 | cylA | 0/0 | 100.0 | 99.8 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 9132 | 11276 | cylB | 0/0 | 100.0 | 99.8 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 6913 | 7896 | cylI | 0/0 | 100.0 | 97.3 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 14555 | 14761 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 11288 | 14269 | cylM | 0/0 | 100.0 | 99.7 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 14880 | 15164 | cylR1 | 0/0 | 100.0 | 100.0 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 15165 | 15365 | cylR2 | 0/0 | 100.0 | 100.0 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00024 | 14330 | 14521 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 508008 | 511319 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 506574 | 508004 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 504694 | 506577 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00004 | 182154 | 186071 | EF0149 | 0/0 | 100.0 | 100.0 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00011 | 39352 | 40278 | efaA | 0/0 | 100.0 | 99.3 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00004 | 131651 | 137614 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00010 | 88814 | 92041 | fss3 | 0/0 | 100.0 | 99.4 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00014 | 22144 | 23676 | gelE | 0/0 | 100.0 | 98.9 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00016 | 30817 | 34734 | prgB/asc10 | 2/4 | 100.0 | 94.7 | NP_817031 | (prgB/asc10) aggregation substance PrgB/Asc10 [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00014 | 21241 | 22095 | sprE | 0/0 | 100.0 | 98.5 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00001 | 503756 | 504600 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Contig | Start | End | Gene | Gaps | Coverage | Identity | Accession | Product |
|---|---|---|---|---|---|---|---|---|
| contig00002 | 121590 | 122600 | bopD | 0/0 | 100.0 | 98.8 | NP_814691 | (bopD) sugar-binding transcriptional regulator LacI family [BopD (VF0362)] [Enterococcus faecalis V583] |
| contig00006 | 194106 | 194921 | cpsA | 0/0 | 100.0 | 99.1 | NP_816141 | (cpsA) undecaprenyl diphosphate synthase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00006 | 193309 | 194109 | cpsB | 0/0 | 100.0 | 99.2 | NP_816140 | (cpsB) phosphatidate cytidylyltransferase [Capsule (VF0361)] [Enterococcus faecalis V583] |
| contig00020 | 7897 | 9135 | cylA | 0/0 | 100.0 | 99.8 | AAM75253 | (cylA) cytolysin activator [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 9132 | 11276 | cylB | 0/0 | 100.0 | 99.8 | AAM75252 | (cylB) ABC-type transporter [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 6913 | 7896 | cylI | 0/0 | 100.0 | 97.3 | AAM75254 | (cylI) cytolysin immunity protein [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 14555 | 14761 | cylL | 0/0 | 100.0 | 100.0 | AAM75249 | (cylL) CylL; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 11288 | 14269 | cylM | 0/0 | 100.0 | 99.7 | AAM75251 | (cylM) CylM; cytolysin subunit modifier [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 14880 | 15164 | cylR1 | 0/0 | 100.0 | 100.0 | AAM75248 | (cylR1) cytolysin regulator R1 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 15165 | 15365 | cylR2 | 0/0 | 100.0 | 100.0 | AAM75247 | (cylR2) cytolysin regulator R2 [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00020 | 14330 | 14521 | cylS | 0/0 | 100.0 | 100.0 | AAM75250 | (cylS) CylS; cytolysin subunit [Cytolysin (VF0356)] [Enterococcus faecalis str. MMH594] |
| contig00001 | 508008 | 511319 | ebpA | 0/0 | 100.0 | 99.5 | NP_814821 | (ebpA) endocarditis and biofilm-associated pilus tip protein EbpA [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 506574 | 508004 | ebpB | 0/0 | 100.0 | 99.4 | NP_814822 | (ebpB) endocarditis and biofilm-associated pilus minor subunit EbpB [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00001 | 504694 | 506577 | ebpC | 1/6 | 100.0 | 99.4 | NP_814823 | (ebpC) endocarditis and biofilm-associated pilus major subunit EbpC [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| contig00004 | 182154 | 186071 | EF0149 | 0/0 | 100.0 | 100.0 | NP_813951 | (EF0149) aggregation substance [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00009 | 102987 | 106849 | EF3023 | 0/0 | 93.8 | 98.7 | NP_816637 | (EF3023) polysaccharide lyase family 8 [Hyaluronidase (VF0359)] [Enterococcus faecalis V583] |
| contig00011 | 39052 | 39978 | efaA | 0/0 | 100.0 | 99.3 | NP_815739 | (efaA) endocarditis specific antigen [EfaA (VF0354)] [Enterococcus faecalis V583] |
| contig00004 | 131651 | 137614 | fss1 | 0/0 | 100.0 | 99.1 | NP_813892 | (fss1) Enterococcus faecalis surface protein Fss1 fibrinogen binding protein [Fibrinogen binding protein (AI271)] [Enterococcus faecalis V583] |
| contig00010 | 88814 | 92041 | fss3 | 0/0 | 100.0 | 99.4 | NP_815578 | (fss3) Enterococcus faecalis surface protein Fss3 fibrinogen binding protein [Fibrinogen binding protein (AI273)] [Enterococcus faecalis V583] |
| contig00007 | 155106 | 156638 | gelE | 0/0 | 100.0 | 98.9 | NP_815516 | (gelE) coccolysin [Gelatinase (VF0357)] [Enterococcus faecalis V583] |
| contig00016 | 29918 | 33835 | prgB/asc10 | 2/4 | 100.0 | 94.7 | NP_817031 | (prgB/asc10) aggregation substance PrgB/Asc10 [AS (VF0352)] [Enterococcus faecalis V583] |
| contig00007 | 154203 | 155057 | sprE | 0/0 | 100.0 | 98.5 | NP_815515 | (sprE) serine proteinase V8 family [SprE (VF0358)] [Enterococcus faecalis V583] |
| contig00001 | 503756 | 504600 | srtC | 0/0 | 98.8 | 99.3 | NP_814824 | (srtC) sortase [Ebp pili (VF0538)] [Enterococcus faecalis V583] |
| Symbol | Meaning |
|---|---|
| ~ | novel full length allele similar to match |
| ? | partial match to known allele |
| - | allele missing |
| Scheme | ST | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|---|---|
| SRR8948878 | efaecalis | 16 | gdh(5) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(7) | yqiL(6) |
| SRR8948879 | efaecalis | 40 | gdh(3) | gyd(6) | pstS(23) | gki(12) | aroE(9) | xpt(10) | yqiL(7) |
| SRR8948880 | efaecalis | 16 | gdh(5) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(7) | yqiL(6) |
| SRR8948881 | efaecalis | 40 | gdh(3) | gyd(6) | pstS(23) | gki(12) | aroE(9) | xpt(10) | yqiL(7) |
| SRR8948882 | efaecium | 80 | atpA(9) | ddl(1) | gdh(1) | purK(1) | gyd(12) | pstS(1) | adk(1) |
| SRR8948883 | efaecium | 203 | atpA(15) | ddl(1) | gdh(1) | purK(1) | gyd(1) | pstS(20) | adk(1) |
| SRR8948884 | efaecalis | 40 | gdh(3) | gyd(6) | pstS(23) | gki(12) | aroE(9) | xpt(10) | yqiL(7) |
| SRR8948885 | - | - | |||||||
| SRR8948886 | efaecium | 1446 | atpA(11) | ddl(13) | gdh(18) | purK(15) | gyd(10) | pstS(19) | adk(6) |
| SRR8948887 | efaecalis | 40 | gdh(3) | gyd(6) | pstS(23) | gki(12) | aroE(9) | xpt(10) | yqiL(7) |
| SRR8948888 | efaecalis | 179 | gdh(5) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(1) | yqiL(6) |
| SRR8948889 | efaecalis | - | gdh(5,92) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(1) | yqiL(6) |
| SRR8948890 | efaecalis | 179 | gdh(5) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(1) | yqiL(6) |
| SRR8948891 | efaecalis | 179 | gdh(5) | gyd(1) | pstS(1) | gki(3) | aroE(7) | xpt(1) | yqiL(6) |
| Genes | Description | Number |
|---|---|---|
| Core genes | (99% <= strains <= 100%) | 0 |
| Soft core genes | (95% <= strains < 99%) | 0 |
| Shell genes | (15% <= strains < 95%) | 5574 |
| Cloud genes | (0% <= strains < 15%) | 5418 |
| Total genes | (0% <= strains <= 100%) | 10992 |